Chemical Mechanisms of Cerebral Ischemia–Reperfusion Injury and Neuroprotection in the Thrombectomy Era
- 1Department of Neurology, School of Medicine, Democritus University of Thrace, University General Hospital of Alexandroupolis, 68100 Alexandroupolis, Greece
- 2Department of Chemistry, Biochemistry and Pharmaceutical Sciences, University of Bern, 3012 Bern, Switzerland
Abstract
Mechanical thrombectomy has significantly improved outcomes for patients with large-vessel occlusion stroke. However, restoring the artery does not always re-establish full microvascular blood flow, tissue rescue, or a good neurological outcome. Ischemia–reperfusion injury varies over time, with distinct biochemical mechanisms dominating during ischemia, early reperfusion, and the subsequent hours. During ischemia, factors like adenosine triphosphate (ATP) depletion, ionic imbalance, calcium overload, mitochondrial dysfunction, acidosis, and metabolic changes such as succinate build-up render brain tissue highly vulnerable. When blood flow resumes, oxygen delivery to this stressed tissue can induce rapid mitochondrial redox shifts, electron leakage, reactive oxygen and nitrogen species formation, iron-dependent radical generation, and lipid peroxidation. Damage may then persist for hours through ongoing mitochondrial dysfunction, phospholipid hydroperoxide accumulation, reactive aldehydes, ferroptosis, blood–brain barrier breakdown, microvascular issues, and inflammation. Much of the mechanistic evidence supporting these processes derives from experimental studies, and their relevance to clinical outcomes after thrombectomy requires further validation. This narrative review tracks these chemical changes across the main phases of cerebral ischemia–reperfusion injury and connects them to modern thrombectomy practices. It also explores how the timing of each process may inform neuroprotective strategies, drug delivery methods, patient selection via imaging, and future clinical trial approaches.
Related
- Blocking FOXO4 confers neuroprotection against oxidative stress and ischemia-reperfusion caused neuronal injury
- Integrated multi-omics reveals gut microbiota–metabolic mechanisms underlying the neuroprotective effects of Xijiao Dihuang Decoction against cerebral ischemia–reperfusion injury
- Discovery of metabolite biomarkers for cerebral ischemia-reperfusion injury based on metabolomics: neurotoxic mechanism and functional validation of a flavopiridol -related metabolite
- Multifaceted neuroprotection of ginsenosides: Mechanisms, nano-delivery advances, and therapeutic potential in central nervous system disorders
- USP11 Drives Cerebral Ischemia–Reperfusion Injury Via Promoting Ferroptosis by Deubiquitinating and Stabilizing ASK1
BibTeX
@article{panos2026chemical,
title = {{Chemical Mechanisms of Cerebral Ischemia–Reperfusion Injury and Neuroprotection in the Thrombectomy Era}},
author = {Leonidas D. Panos and Dib Chakif},
journal = {International Journal of Molecular Sciences},
year = {2026},
month = oct,
doi = {10.3390/ijms27219733},
url = {https://www.mdpi.com/1422-0067/27/21/9733},
note = {CC BY 4.0},
}
RIS
TY - JOUR
TI - Chemical Mechanisms of Cerebral Ischemia–Reperfusion Injury and Neuroprotection in the Thrombectomy Era
AU - Leonidas D. Panos
AU - Dib Chakif
PY - 2026
DA - 2026/10/30
JO - International Journal of Molecular Sciences
DO - 10.3390/ijms27219733
UR - https://www.mdpi.com/1422-0067/27/21/9733
AB - Mechanical thrombectomy has significantly improved outcomes for patients with large-vessel occlusion stroke. However, restoring the artery does not always re-establish full microvascular blood flow, tissue rescue, or a good neurological outcome. Ischemia–reperfusion injury varies over time, with distinct biochemical mechanisms dominating during ischemia, early reperfusion, and the subsequent hours. During ischemia, factors like adenosine triphosphate (ATP) depletion, ionic imbalance, calcium overload, mitochondrial dysfunction, acidosis, and metabolic changes such as succinate build-up render brain tissue highly vulnerable. When blood flow resumes, oxygen delivery to this stressed tissue can induce rapid mitochondrial redox shifts, electron leakage, reactive oxygen and nitrogen species formation, iron-dependent radical generation, and lipid peroxidation. Damage may then persist for hours through ongoing mitochondrial dysfunction, phospholipid hydroperoxide accumulation, reactive aldehydes, ferroptosis, blood–brain barrier breakdown, microvascular issues, and inflammation. Much of the mechanistic evidence supporting these processes derives from experimental studies, and their relevance to clinical outcomes after thrombectomy requires further validation. This narrative review tracks these chemical changes across the main phases of cerebral ischemia–reperfusion injury and connects them to modern thrombectomy practices. It also explores how the timing of each process may inform neuroprotective strategies, drug delivery methods, patient selection via imaging, and future clinical trial approaches.
SN - 1422-0067
ER -